740. Deputy Peadar Tóibín asked the Minister for Health the protocols in place to review and adjust thyroid medication dosages for women following childbirth, particularly where the dosage was increased during pregnancy; in the absence of protocols, the measures that will be taken to ensure that postnatal thyroid treatment is appropriately monitored to avoid adverse effects such as depression and suicidal ideation; a…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
741. Deputy Peadar Tóibín asked the Minister for Health if she is aware of cases in which women have remained on elevated thyroid medication postpartum without review, resulting in serious mental health side effects including depression and suicidal thoughts; and if the HSE has conducted or will conduct any review or audit into such cases. [35519/25]
742. Deputy Peadar Tóibín asked the Minister for Health the clinical guidelines currently in place for general practitioners and endocrinologists regarding the monitoring and adjustment of thyroid hormone levels in postpartum women; and if updated guidance will be issued to ensure safer prescribing practices. [35520/25]
772. Deputy Claire Kerrane asked the Minister for Health if a full HTA application for the drug Veoza has been submitted, and when it is anticipated the HTA will be complete; and if she will make a statement on the matter. [35598/25]
785. Deputy Richard Boyd Barrett asked the Minister for Health the estimated full-year cost of introducing a fully funded universal contraception scheme; and if she will make a statement on the matter. [35677/25]
786. Deputy Richard Boyd Barrett asked the Minister for Health the estimated annual cost of free hormone replacement therapy for anyone who needs it; and if she will make a statement on the matter. [35678/25]
7. Deputy Shane Moynihan asked the Minister for Health if the Belgian model is being examined in the context of the programme for Government commitment to investigate early access schemes for rare disease treatments; and if she will make a statement on the matter. [34617/25]
66. Deputy William Aird asked the Minister for Health the current status of access to spinal muscular atrophy (SMA) treatments for adult patients; if she will commit to ensuring equitable public reimbursement of therapies for adults living with SMA; considering the urgent need expressed by patient groups; and if she will make a statement on the matter. [34829/25]
70. Deputy Conor D. McGuinness asked the Minister for Health if she will implement a plan to support individuals with Duchenne muscular dystrophy, including the development of specialist multidisciplinary teams, and ensuring enhanced and immediate access to givinostat and similar treatments. [34818/25]
95. Deputy Pádraig O'Sullivan asked the Minister for Health the progress her Department has made in honouring the Programme for Government commitment that an early access programme for medicines would be established; and if she will make a statement on the matter. [34979/25]
197. Deputy Colm Burke asked the Minister for Health if she will prioritise the Programme for Government commitment to investigate early access schemes for orphan medicines; and if she will make a statement on the matter. [34701/25]
787. Deputy Robert O'Donoghue asked the Minister for Health if there are plans to change the timely access to the drug givinostat required to help treatment for persons with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33827/25]
799. Deputy Martin Daly asked the Minister for Health if there are plans to introduce skyclarys (omaveloxolone) into the Irish market for the treatment of Friedreich's ataxia in adults and adolescents; which is approved in America, Canada, UK, some European countries but not Ireland to date; and if she will make a statement on the matter. [33909/25]
832. Deputy Willie O'Dea asked the Minister for Health if she will accelerate the approval and funding of the new drug givinostat to treat the one-hundred boys currently living with Duchenne muscular dystrophy in Ireland; and if she will make a statement on the matter. [34122/25]
385. Deputy Robert O'Donoghue asked the Minister for Health if she will address the situation regarding the unavailability of phyllocontin and uniphyllin (theophylline) tablets, which were previously used to manage asthma and were covered under the medical card scheme; if uniphyllin continus PR, which is believed to be the replacement, will be made available under the medical card given its high monthly cost; and if …
388. Deputy Aisling Dempsey asked the Minister for Health the actions she will take to ensure that givinostat is available at the earliest opportunity to sufferers of Duchenne muscular dystrophy. [33245/25]
402. Deputy Albert Dolan asked the Minister for Health if she will provide an update on the current status of the approval process for the drug givinostat for patients with Duchenne muscular dystrophy; if consideration is being given to its inclusion in an early access programme, similar to those operating in the United Kingdom and the United States; and if she will make a statement on the matter. [33312/25]
403. Deputy Ruth Coppinger asked the Minister for Health to outline her engagements with the HSE on access to givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [33325/25]
412. Deputy Eoin Ó Broin asked the Minister for Health if she will use her power to ensure a decision is made as a matter of urgency regarding an application for reimbursement of new medicines (details supplied) given lengthy reimbursement times and the detrimental impact delaying access to this medicine has on the medical condition to which it relates. [33380/25]
423. Deputy Barry Heneghan asked the Minister for Health the steps she is taking to ensure that a drug (details supplied) will be assessed and made available as quickly as possible following its recent EU approval, given how important early access is for children with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33451/25]
141. Deputy Seán Ó Fearghaíl asked the Minister for Health if she will address concerns outlined in correspondence (details supplied) regarding the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [32876/25]
143. Deputy Mark Ward asked the Minister for Health if she will meet members of the group who made a presentation on Duchenne muscular dystrophy on 11 June 2025 in Leinster House as they try to access a new drug called givinostat; and if she will make a statement on the matter. [32910/25]
150. Deputy Brendan Smith asked the Minister for Health to report on the progress being made regarding the provision of givinostat (brand name duvyzat) for the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [32923/25]
153. Deputy Eoin Hayes asked the Minister for Health when all adults living with spinal muscular atrophy will be entitled to the same treatments as children living with spinal muscular atrophy in Ireland; and if she will make a statement on the matter. [32936/25]
156. Deputy Claire Kerrane asked the Minister for Health if she will seek access to the early access programme for givinostat for patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33019/25]